Skin cancer drug fast tracked under early access to medicines schemeA drug for advanced skin cancer, pembrolizumab, has become the first medicine to be fast tracked to patients under the UK’s early access to medicines scheme.…
Rita Scanlon diesOn 19 February 2015, Rita Scanlon MRPharmS, aged 84, of 10 Scarborough Road, Shipley BD18 3DR. Miss Scanlon registered with the Society in 1954.…
Francis Jamieson diesOn 2 March 2015, Francis Jamieson MRPharmS, aged 83, of Hurstwood, The Manor House, Eyhurst Park, Tadworth KT20 6JR. Mr Jamieson registered with the Society in 1956.…
John Nicholas Staniforth diesOn 6 March 2015, John Nicholas Staniforth, aged 61, of The Byre, Claverton, Bath BA2 7BG. Mr Staniforth registered with the Society in 1976. He left the Society in 2014.…
Antioxidant prevents weight gain but effect in mice only seen in females A naturally occurring antioxidant — 7,8-dihydroxyflavone (7,8-DHF) — mimics brain-derived neurotrophic factor (BDNF), a hormone secreted after physical exercise that controls weight gain.…
Liver impairment: ensuring medicines safety How liver disease can affect absorption and excretion and the clinical consequences for common medicines.…
Global alliance of pharmacy schools launched to boost joint researchA global alliance of pharmacy schools based in the UK, Australia and the United States has been launched to boost joint international research.…
2015 elections to the national pharmacy boardsThe 2015 elections to the three national pharmacy boards are vitally important to the continued success of the Society, which depends on a vibrant, engaged and committed membership. All members and Fellows have an opportunity, through involvement in the election process, to participate …
Statins increase risk of type 2 diabetes, study suggests The use of statins increases the risk of developing type 2 diabetes by 46%, even after adjusting for confounding factors, according to a study published in Diabetologia.…
EMA recommends treatment for rare kidney condition The European Medicines Agency has recommended the approval of tolvaptan for the treatment of a rare inherited disease, autosomal dominant polycystic kidney disease.…
